BGLC
BGLC
NASDAQ · Trading Companies & Distributors

Bionexus Gene Lab Corp

$2.11
+0.12 (+6.03%)
As of Feb 8, 2:33 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.54M 1.58M 1.38M
Net Income 115.8K 149.1K 96.1K
EPS
Profit Margin 7.5% 9.4% 7.0%
Rev Growth +19.7% +23.5% +22.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 875.9K 748.7K 864.2K
Total Equity 2.90M 3.20M 3.19M
D/E Ratio 0.30 0.23 0.27
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 175.4K 198.9K 172.0K
Free Cash Flow 153.2K 98.9K 88.8K